Kestrel Therapeutics focuses on developing therapies targeting KRAS mutations in cancer, aiming to exploit oncogene addiction for effective drug development
Kestrel Therapeutics focuses on developing therapies targeting KRAS mutations in cancer, aiming to exploit oncogene addiction for effective drug development.